Triamcinolone and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone (triamcinolone) and Taltz (ixekizumab). Common drug interactions include iron deficiency anaemia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Triamcinolone and Taltz. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,778 Taltz users. Check the latest studies of Taltz.

On Aug, 12, 2026

61 people who take Triamcinolone and Taltz together, and have interactions are studied.

Triamcinolone and Taltz drug interactions.

What are the common drug interactions of Triamcinolone and Taltz, by gender? *:

female:

Iron deficiency anaemia
Myalgia (muscle pain)
Pain
Papule
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Skin mass
Tooth infection
Anger
Breast cancer
Cardiac failure

male:

Drug ineffective
Psoriasis (immune-mediated disease that affects the skin)
Anal abscess
Cough
Fungal infection
Gout (uric acid crystals building up in the body)
Headache (pain in head)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Leukopenia (less number of white blood cells in blood)
Myalgia (muscle pain)

What are the common drug interactions of Triamcinolone and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site erythema (redness at injection site)

30-39:

Injection site pain
Psoriasis (immune-mediated disease that affects the skin)

40-49:

Psoriasis (immune-mediated disease that affects the skin)
Arthralgia (joint pain)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Iron deficiency anaemia
Myalgia (muscle pain)
Papule
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rash erythematous (redness of the skin)
Rash pruritic (redness with itching)

50-59:

Drug ineffective
Headache (pain in head)
Injection site bruising
Injection site pain
Diarrhoea
Nausea (feeling of having an urge to vomit)
Psoriasis (immune-mediated disease that affects the skin)
Rash
Gallbladder disorder
Injection site erythema (redness at injection site)

60+:

Rash
Rash pruritic (redness with itching)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)
Vitamin b12 decreased
Psoriasis (immune-mediated disease that affects the skin)
Cardiac failure
Death
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Eye irritation

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 45 people, 73.77%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 11.48%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 9.84%
Asthma: 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously